DD
T2DuPont de Nemours, Inc.
OverviewDuPont de Nemours, Inc. (DD) provides advanced materials and solutions globally, operating through Health Care & Water Technologies (~48% of Q1 2026 sales) and
DuPont de Nemours, Inc. (DD) provides advanced materials and solutions globally, operating through Health Care & Water Technologies (~48% of Q1 2026 sales) and Diversified Industrials (~52%). Health Care & Water offers medical packaging, biopharma, and water purification. Diversified Industrials serves aerospace, automotive (including EV battery adhesives), and construction. The company leverages innovation, digital, and AI to deliver specialized products.
- What They Do (Plain English & Analogies)
- DuPont is like a specialized ingredient supplier for many different industries. Instead of making finished products you buy in a store, they create the advanced materials and solutions that other companies use to make their products better, safer, or more efficient. Think of them as providing the "super-ingredients" for things like medical devices, water filters, car parts, and electronic components. For example, they make special films that protect satellites from extreme temperatures, materials that purify drinking water, and strong, lightweight components for electric vehicles. They essentially help other businesses innovate and solve complex material challenges.
- Very Brief History
- DuPont was founded in 1802 by Éleuthère Irénée du Pont de Nemours as a gunpowder mill in Delaware. Over two centuries, it evolved into one of the world's largest diversified chemical companies, developing iconic products like nylon, Teflon, Mylar, Kapton, and Kevlar. In 2017, it merged with Dow Chemical Company to form DowDuPont, which then split into three independent companies in 2019: Corteva (agrisciences), Dow Chemical Company (materials sciences), and DuPont de Nemours, Inc. (specialty products). More recently, in April 2026, DuPont divested its Aramids business.
- "Street Stereotype"
- DuPont is generally perceived as a global specialty chemicals and advanced materials company with a long history of innovation, but also one that has undergone significant portfolio transformation and divestitures in recent years. Investors and analysts often view it as a company focused on high-margin, technology-driven solutions, particularly in healthcare and water technologies, while also navigating cyclicality in industrial markets. There's a focus on its ability to drive growth through innovation, disciplined capital allocation, and operational excellence, including the implementation of strategies like 80/20.
- Subsidiaries On Linked In*
- {"subsidiaries":[]}
- Customer Sectors & Example Clients
- DuPont's customers operate in a wide array of sectors including healthcare (medical packaging, biopharma, medical devices), water (industrial water, municipalities, drinking water utilities, microelectronics), diversified industrials (aerospace, automotive, building technologies, industrial technologies, printing and packaging, consumer goods, clean energy). While specific client names are not provided in the transcript, based on their business model and industries, likely clients would include: medical device manufacturers (e.g., Medtronic, Johnson & Johnson), pharmaceutical companies, municipal water treatment facilities, semiconductor manufacturers (e.g., Intel, TSMC), major automotive OEMs (e.g., Ford, GM, Tesla), aircraft manufacturers (e.g., Boeing, Airbus), and construction companies.
- New Customers / Segments They'Re Targeting
- DuPont is actively targeting growth in the healthcare sector, specifically looking to expand its offerings in medical packaging and the CDMO (Contract Development and Manufacturing Organization) side of biopharma. They are also focused on growing their presence in the electric vehicle (EV) market, particularly with battery adhesive volumes, and have secured new wins with large OEMs. Additionally, they are leveraging digital and AI capabilities to accelerate product development and improve customer solutions across various end markets.
- Supply Chain And Sourcing Geographies
- DuPont operates a global supply chain. The transcript highlights that the Middle East conflict has caused logistics disruptions, particularly impacting their water business, with some materials unable to ship out of the region. They also mentioned a site in Saudi Arabia that experienced some disruption. While specific sourcing countries are not exhaustively listed, the company has a global manufacturing and sourcing footprint, and the ability to move product around its supply chain to mitigate headwinds (e.g., tariffs, Middle East disruptions) suggests a diversified sourcing strategy.
- Sales Geographies And Expansion Plans
- DuPont sells its products globally, serving markets across North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific region. The transcript mentions strong order growth trends across the majority of their businesses. While no explicit plans for expanding into entirely new *geographical regions* were disclosed in the transcript, the company is focused on driving growth within its existing global footprint by leveraging innovation and commercial execution in attractive end markets like healthcare and aerospace. They also mentioned large projects in the Middle East around "the [indiscernible]" (likely NEOM or similar large-scale developments) for their water business.
- How Key Themes May Help/Hurt
- **Help from 'Space Supply Chain '26: Aerospace Composites, Materials & Alloys':** DuPont is well-positioned to benefit from this theme. Their Kapton polyimide films are essential for thermal management in satellites, and Kevlar (though recently divested, its historical association and continued use of advanced materials in aerospace are relevant) is used for micrometeoroid shielding. The transcript mentions "continued strength in aerospace" as a driver for their Diversified Industrials segment. As space exploration and satellite deployment increase, demand for high-performance, lightweight, and durable materials like those offered by DuPont will likely grow, contributing to their revenue and market position in this niche but critical sector. **Help from 'AI Bottleneck '26: Upstream AI Materials':** DuPont's Electronics & Industrial segment (though not explicitly detailed in the transcript, the existing knowledge base mentions it) supplies critical materials for semiconductor and integrated circuit manufacturing. The "Bull1" point of the AI theme highlights accelerating demand for advanced semiconductor materials and packaging driven by next-generation AI hardware. DuPont's investments in digital and AI capabilities and its collaboration with an AI-driven platform for product development also align with this theme, potentially leading to new material solutions for AI-specific applications. The transcript mentions strength in microelectronics markets within their water business, driven by the broader data center trend, which is a core component of AI infrastructure.
3 Main Long-Term Bull Details
- Strong Innovation Engine and Sustainability Focus: DuPont's commitment to sustainable innovation, reflected in its 2026 sustainability report and new 2035 goals, drives the creation of advanced solutions that help customers succeed. Their high "Vitality Index" (35% above benchmark in 2025) indicates a strong and relevant product portfolio, with continuous new product introductions across high-growth markets like healthcare and water.
- Growth in Healthcare & Water Technologies: The company is strategically positioned in high-growth areas like medical packaging, biopharma, and industrial water, driven by global megatrends such as an aging population, increased healthcare access, and the need for clean water. Management aims to shift the company's portfolio more towards this segment (targeting 2/3 Health Care & Water, 1/3 Diversified Industrials over the medium term), indicating a clear growth strategy.
- Disciplined Capital Allocation and M&A Opportunities: DuPont demonstrates a commitment to returning cash to shareholders through share repurchases and maintains a prudent M&A strategy. With proceeds from divestitures (like Aramids) and a strong balance sheet, they have "dry powder" to pursue accretive growth deals, particularly in healthcare, to further round out their portfolio and drive long-term value creation.
3 Main Long-Term Bear Details
- Exposure to Macroeconomic and Geopolitical Headwinds: Despite efforts to build resilience, DuPont remains susceptible to dynamic external environments, including potential macro and geopolitical headwinds. The Middle East conflict, for instance, caused logistics disruptions and impacted sales in the water business, requiring price increases to offset higher input costs. Continued or escalating global instability could negatively impact demand, supply chains, and profitability.
- Cyclicality in Diversified Industrial Markets: Segments like construction and certain printing and packaging businesses continue to experience softness or cyclical weakness. While some areas like automotive (EV battery adhesives) show strength, overall demand in diversified industrials can be uneven, potentially dampening overall revenue growth and margins, as seen with the low single-digit decline in building technologies in Q1 2026.
- Operational Execution and Margin Pressures: While the company is focused on operational excellence and margin expansion (e.g., through 80/20 strategy and Kaizen events), challenges such as managing increased input costs (e.g., HDPE, energy) and ensuring timely supply can create margin pressures. Shifts in product mix or unforeseen operational disruptions could hinder the achievement of margin expansion targets.
- Competitors And Differentiation
- DuPont operates in diverse markets, so its competitors vary by segment. * **Advanced Materials/Specialty Chemicals:** Competitors could include BASF SE, Celanese Corporation, Covestro AG, SABIC, LG Chem Ltd., and other large chemical and materials science companies. * **Water Technologies:** Competitors in water purification and separation could include companies like SUEZ, Veolia, Xylem, and other specialized water technology providers. * **Medical Packaging/Devices:** Competitors would include other specialized material providers for medical applications. * **Electronics & Industrial:** Competitors in semiconductor materials and advanced printing solutions. * **Differentiation:** DuPont differentiates itself through its strong innovation engine, developing sustainably advanced solutions, and a robust product portfolio (e.g., FILMTEC nanofiltration elements, Tyvek for medical packaging, Liveo for biopharma, battery adhesives for EVs). They emphasize operational excellence, a performance-based culture, and strategic capital allocation. Their long history and established brands also contribute to their competitive positioning.
- Recent Performance & What The Market'S Focused On
- DuPont reported a strong first quarter 2026, exceeding guidance with 2% organic sales growth, 130 basis points of pro forma margin expansion, and double-digit adjusted EPS growth. They raised their full-year 2026 financial guidance, now expecting net sales of about $7.185 billion and adjusted EPS of $2.35 to $2.40 per share. The market is focused on the company's ability to sustain this momentum, particularly the strong margin performance driven by favorable mix and productivity actions. Key areas of market attention include the impact and mitigation of the Middle East conflict on logistics and costs, the continued growth in healthcare and aerospace, the ongoing weakness in construction, the progress of the 80/20 strategy in Diversified Industrials, and the disciplined capital allocation strategy, including share repurchases and potential M&A.
- Revenue Segments And Estimated Mix
- Healthcare & Water Technologies — Mix: ~47.4%; Source: Q1 2026 transcript; Trend: Organic sales growth of 3% YoY in Q1 2026, with high single-digit growth in healthcare and low to mid-single digit decline in water (due to logistics disruptions). Expected mid-single digit organic growth for Q2.
- Diversified Industrials — Mix: ~51.5%; Source: Q1 2026 transcript; Trend: Organic sales growth about flat YoY in Q1 2026, with low single-digit decline in building technologies and low single-digit growth in industrial technologies. Expected low single-digit organic growth for Q2.
- Product Brands
- FILMTEC
- Tyvek
- Liveo
- Amberlite
- Tychem
- INGE
- ITEGRATEC
- CORIAN
- Vespel
- MOLYKOTE
- BETAFORCE
- BETASEAL
- Kapton
- Tedlar
- MemCor
- OxyMem
- Artistri Digital Inks
- Cyrel Flexographic Solutions
Key Factors
| Key Factor | Why It Matters | What To Watch | What It Signals | Where/How To Track | Free Alt Data | Paid Alt Data |
|---|---|---|---|---|---|---|
| Progress on 80/20 Process Implementation and Stranded Cost Reduction | These internal initiatives are designed to enhance operational efficiency, improve margin profiles, and reduce costs, directly contributing to the company's long-term profitability and strategic objectives, reinforcing the bull case. | Updates on the progress of the 80/20 process in Diversified Industrials (currently 2/3 through initial study in 4 businesses). Specifics on the realization of the $10 million stranded cost reduction target for full-year 2026 and progress towards the full $30 million target within two years. | Bullish if the company reports ahead-of-schedule progress on 80/20 implementation with tangible margin benefits, or if stranded cost reductions exceed the $10 million target for 2026. Bearish if implementation faces significant delays or cost reduction targets are missed. | Company's Q2 2026 earnings call and investor presentations on Tuesday, August 4, 2026. | Company career pages: Job postings related to operational excellence/process improvement roles; Industry publications on operational efficiency best practices. | Thinknum Alternative Data: Job postings analysis for operational roles; Gartner: Research on operational excellence and business system implementation. |
| Organic Sales Growth in Health Care & Water Technologies and Aerospace/EV segments | Strong organic growth in these key segments validates DuPont's strategic focus on high-growth, differentiated markets and indicates robust underlying demand for its specialized materials, confirming the long-term investment thesis. | Q2 2026 organic sales growth for Health Care & Water Technologies (guidance: mid-single digits percent range) and Diversified Industrials (guidance: low single digits percent range, driven by aerospace/automotive). Also, full-year 2026 organic growth (guidance: ~4%). | Bullish if Health Care & Water organic growth exceeds mid-single digits and Diversified Industrials organic growth exceeds low single digits in Q2, or if full-year organic growth guidance is raised above 4%. Bearish if Q2 segment organic growth falls below guidance or full-year guidance is lowered. | Company's Q2 2026 earnings report and conference call transcript on Tuesday, August 4, 2026. | Industry reports on medical device, biopharma, industrial water, aerospace, and EV production/sales trends (e.g., IATA for aerospace, EV sales data from government agencies or industry associations). | S&P Global Market Intelligence: Industry-specific growth forecasts; Bloomberg Terminal: Segmental revenue estimates and revisions. |
| Capital Allocation - New Share Repurchase Authorizations or Accretive M&A Announcements | Disciplined capital allocation, including returning cash to shareholders and pursuing strategic, growth-accretive acquisitions, enhances shareholder value and reshapes the portfolio towards higher-growth areas, confirming the long-term strategy. | Any announcements of further accelerated share repurchases beyond the $275 million announced, or new M&A deals, particularly in the Health Care & Water Technologies space, leveraging the remaining Aramids proceeds. | Bullish if the company announces additional significant share repurchase programs or a strategic acquisition that is accretive to growth and aligns with the 2/3 Health Care & Water portfolio shift goal. Bearish if capital is deployed in non-accretive ways or if M&A activity is delayed. | Company press releases, SEC filings (8-K for material events), and investor presentations. | SEC EDGAR: Form 8-K filings for M&A or share repurchase announcements; Financial news aggregators. | MergerMarket: M&A deal flow and rumors; Bloomberg Terminal: Capital allocation analysis and M&A screening. |
| Impact of Middle East Conflict on Water Business & Supply Chain | Geopolitical stability and supply chain resilience are critical. Any escalation or new disruptions could negatively impact sales, costs, and project timelines, particularly for the water business, invalidating current guidance. | Any new announcements regarding shipping disruptions, surcharges, or project delays in the Middle East region. Specifically, monitoring the status of large water projects in the Middle East (e.g., NEOM) expected in H2 2026. | Bullish if the conflict de-escalates or if the company announces further successful mitigation strategies with no material impact on H2 water projects. Bearish if new significant disruptions occur, leading to further sales shortfalls or increased costs beyond current pricing actions. | Company press releases, SEC filings, geopolitical news outlets, and Q2 2026 earnings call commentary on Tuesday, August 4, 2026. | MarineTraffic/VesselFinder: Shipping traffic through key chokepoints (e.g., Bab el-Mandeb Strait); Reuters/Bloomberg: Geopolitical news updates on the Middle East. | Supply Chain Brain: Real-time supply chain disruption alerts; Kpler: Global freight and commodity flow data. |
| Operating EBITDA Margin Expansion | Sustained margin expansion, driven by favorable mix and productivity, demonstrates effective cost management and pricing power, crucial for achieving long-term profitability targets and enhancing shareholder value. | Q2 2026 operating EBITDA margin (guidance: ~23.9% based on $430M EBITDA on $1.8B sales). Also, full-year 2026 operating EBITDA (guidance: ~$1.745 billion) and any updates on pro forma margin expansion. | Bullish if Q2 operating EBITDA margin exceeds ~23.9% or if full-year operating EBITDA guidance is raised. Bearish if Q2 margin falls below expectations or full-year guidance is lowered. | Company's Q2 2026 earnings report and conference call transcript on Tuesday, August 4, 2026. | Producer Price Index (PPI) for chemical manufacturing; U.S. Bureau of Labor Statistics: Productivity and costs data for manufacturing. | FactSet: Consensus margin estimates and revisions; IHS Markit: Raw material price forecasts for key inputs. |
Key Reported Metrics, Reratings Triggers & ResultsOperating EBITDA is a crucial profitability metric for DuPont, reflecting the company's operational efficiency and ability to expand margins. Strong EBITDA grow
| Key reported metrics | Rerating thresholds | ||||
|---|---|---|---|---|---|
| Metric | Last period | Why it matters | What's needed for rerating | Rerating context | Earnings date |
| Operating EBITDA | 15% | Operating EBITDA is a crucial profitability metric for DuPont, reflecting the company's operational efficiency and ability to expand margins. Strong EBITDA growth signals effective cost management and favorable mix. | For DuPont de Nemours, Inc. (DD) to rerate higher, the Operating EBITDA margin needs to hit 25% or higher in Q2 2026, significantly exceeding the current Q2 2026 implied guidance of approximately 23.89% (based on estimated operating EBITDA of $430 million and net sales of $1.8 billion) and improving on the Q1 2026 reported margin of 24.6%. Additionally, a higher rerating would likely require a corresponding increase in the full-year 2026 Operating EBITDA guidance beyond the current ~$1.745 billion, implying a full-year margin of at least 24.5%. | Achieving 25%+ Operating EBITDA margin and raising full-year guidance signals superior operational execution and cost management. This validates DuPont's strategic pivot and productivity, reinforcing margin durability and disciplined capital allocation, leading to a higher valuation multiple as investor confidence grows. | |
| Organic Sales Growth | 2% | This metric indicates the underlying health and demand for DuPont's products, excluding currency impacts and acquisitions/divestitures. It's a key indicator of top-line performance and market penetration. | For DuPont de Nemours, Inc. (DD) to rerate higher, the company needs to report Q2 2026 organic sales growth of at least 4%, exceeding its current guidance of approximately 3%. Additionally, it must raise its full-year 2026 organic sales growth outlook to 5% or more, surpassing its current guidance of approximately 4%. This would represent a significant acceleration beyond current company and analyst expectations. | Achieving this threshold would signal a significant acceleration beyond current guidance and analyst expectations, validating DuPont's strategic shift towards high-growth segments like Health Care & Water Technologies. This sustained top-line momentum would demonstrate effective operational execution and a stronger competitive position, driving a positive rerating by confirming the long-term investment thesis. | |
| Health Care & Water Technologies Organic Sales Growth | 3% | This segment is a strategic growth driver for DuPont, with a stated goal to shift the portfolio towards this area. Its organic sales growth highlights success in key end markets like medical packaging, biopharma, and industrial water. | For DuPont de Nemours, Inc. (DD) to rerate higher, the Health Care & Water Technologies Organic Sales Growth metric needs to hit at least high single-digits (7-9%) for Q2 2026, significantly exceeding the Q1 2026 value of 3% and the company's Q2 guidance of mid-single-digit growth for the segment. Additionally, it needs to demonstrate a clear path to sustained high single-digit or low double-digit growth (10%+) for the full year. | Achieving this threshold validates DuPont's strategic pivot towards high-growth Health Care & Water Technologies, demonstrating successful execution in key markets. It signals accelerated growth prospects and a more favorable business mix, crucial for a positive rerating and long-term shareholder value. | |
Earnings Transcript Summary
· 2026Q1 Earnings Call
| 3 Things Management Is Most Focused On | Call Takeaway & Tone | Prior Quarter'S Y/Y Growth By Segment | 3 Things Analysts Most Pressed On (And Mgmt Responses) | Revenue Segments |
|---|---|---|---|---|
| 1. Driving growth and continuous improvement: Management is focused on strengthening its performance-based culture, emphasizing innovation, commercial execution, and operational excellence, supported by the implementation of its business system and digital/AI capabilities. 2. Disciplined capital allocation: DuPont is committed to returning cash to shareholders, as evidenced by the announced $275 million accelerated share repurchase, and is prudently evaluating M&A opportunities for accretive growth, leveraging proceeds from the Aramids divestiture. 3. Sustainability: The company recently issued its 2026 sustainability report and announced new 2035 sustainability goals, focusing on sustainable innovation, resilient operations, and people, partners, and communities to drive growth and operational excellence. | The overall takeaway of the call was positive, highlighting DuPont's strong operational start to 2026, with results exceeding guidance and a subsequent raise in full-year financial outlook. The tone was confident and optimistic, emphasizing disciplined execution, robust margin expansion driven by both favorable mix and productivity, and solid free cash flow generation despite external macro and geopolitical headwinds. Management expressed confidence in their strategic priorities, including capital allocation, sustainability, and continuous improvement initiatives like the 80/20 process, while actively managing challenges such as Middle East logistics disruptions and raw material inflation through proactive pricing actions. | Healthcare & Water Technologies (Q4 2025): 3% organic sales growth y/y; Diversified Industrials (Q4 2025): 4% organic sales decline y/y. | 1. **Impact of Middle East conflict on the water business and mitigation strategies:** Analysts inquired about the financial impact and customer base disruptions. Management responded that approximately $10 million in water sales were impacted in Q1 but have since shipped in April, and teams have found alternative routes to mitigate disruptions, with minimal impact baked into Q2 guidance. They expect full-year water growth to be mid-single digits, with a stronger second half due to project timing. 2. **Drivers of strong margin expansion and sustainability:** Analysts questioned whether margin expansion was primarily due to mix or operational improvements. Management clarified that both mix (50 basis points) and net productivity (70 basis points) contributed significantly to Q1 margins, indicating strong underlying performance and progress towards their 3-year targets. 3. **Pricing strategy and ability to offset rising input costs:** Analysts asked about the company's ability to push through price increases given rising raw material and logistics costs. Management stated that surcharges and price increases are already in place (starting April 1 or May 1) to cover an expected $90 million in incremental costs, with the organization demonstrating a strong ability to pivot and customers generally being constructive in discussions as the company aims to cover costs, not profit. | Healthcare & Water Technologies: 3% organic sales growth y/y; Diversified Industrials: about flat organic sales growth y/y. |
Transcript Tidbits
| About Expanding Eligible Market | About Competition | About The Broader Industry | Where Things Are Headed | Updates On Theme | Broader Themes Emerging | Bullish-Leaning Quotes (Short) | Bearish-Leaning Quotes (Short) | Hiring |
|---|---|---|---|---|---|---|---|---|
| DuPont intends to continue adding to its health care portfolio, with a robust pipeline of affordable and growth-accretive assets, focusing on broadening its net packaging offering and rounding out sales in the CDMO space. The company aims to shift its portfolio over the medium term to be 2/3 in the Health Care & Water space, moving more towards growth above market. | The transcript does not contain explicit discussions about competition. | The company is navigating potential macro and geopolitical headwinds. There is continued softness in construction markets, particularly North America residential, while commercial and do-it-yourself segments are flattish, excluding data center volume. The overall construction market is expected to be flat for the full year 2026. Strength is noted in health care and aerospace markets. Automotive, specifically battery adhesive volumes for EVs, is showing strong growth, well above the 20% EV growth expectations, due to new volume and wins. The microelectronics market, particularly within ion exchange, is seeing nice volume driven by the broader data center trend. Demand in biopharma is recovering nicely. The printing and packaging businesses are expected to normalize and be up low single digits on a full-year basis. Key global megatrends driving health care demand include the aging population and increased access to health care, particularly for higher-end Class 3 medical devices and cardiovascular applications. | DuPont is raising its full-year 2026 financial guidance following a strong first quarter performance and price increases due to the Middle East conflict. The company expects to launch a $275 million accelerated share repurchase under its existing program. New 2035 sustainability goals have been announced, focusing on sustainable innovation, resilient operations, and people, partners, and communities, designed to drive growth and operational excellence. The implementation of the 80/20 process in Diversified Industrials is expected to lead to nice margin appreciation with minimal top-line impact over time. Approximately $10 million of stranded costs are expected to be removed in 2026, with the full $30 million targeted within the first two years. The water business is projected to be up mid-single digits for the full year, with a flat first half and high single-digit growth in the second half driven by large project timing. The company's full-year guidance anticipates the current Middle East conflict situation, including oil and natural gas prices, to continue through the remainder of the year, with pricing actions already in place to cover incremental costs. Health care sales are expected to be up mid-single digits to high single digits for the full year. DuPont aims to shift its portfolio over the medium term to be 2/3 in the Health Care & Water space. | Aerospace | AI Materials: DuPont is investing in digital and AI capabilities, including a collaboration with an AI-driven platform for end-to-end product and application development to accelerate development and improve cycle times. They are expanding the use of data-enabled tools with AI capabilities to improve maintenance, accelerate defect detection, and optimize asset performance, converting operational data into actionable insights faster. Sustainability: The company issued its 2026 sustainability report and announced new 2035 sustainability goals focused on creating sustainably advanced solutions, reducing environmental footprint, and increasing renewable energy use. Operational Excellence: DuPont is strengthening its performance-based culture with an emphasis on growth and continuous improvement, implementing a business system, and focusing on fundamentals like safety, quality, delivery, inventory, and productivity through initiatives like Kaizen events. | “our first quarter financial results, which exceeded our previously communicated guidance.” “We delivered organic sales growth of 2%, 130 basis points of pro forma margin expansion and double-digit adjusted EPS growth.” “We are well on our way to our 3-year targets that we laid out at our Investor Day.” “Our order trends in April were actually -- we have very similar demand as we have been seeing and nice increases overall on a year-over-year basis.” “We continue to be positioned nicely and realize the pipeline has been building over the last couple of years, frankly, as we got qualifications with the large OEMs.” “free cash flow generation is still expected to be greater than 90% for the year.” “We saw nice volume in the first quarter, as you would expect, just around the broader data center trend.” | “While we are mindful of potential macro and geopolitical headwinds” “continued softness in construction markets and logistics disruptions due to the conflict in the Middle East.” “Our second quarter net sales guidance assumes about 3% organic growth year-over-year. Currency is expected to be a slight tailwind in the quarter.” “overall full year guidance anticipates that the current situation continues through the remainder of the year. So current oil prices, current natural gas prices, our assumption is that continues all year long.” “if this were to escalate or get even worse from where we are today, that would obviously have some impact on the assumptions that we've made” |